Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001185185-11-001665
Filing Date
2011-09-29
Accepted
2011-09-29 16:57:45
Documents
9
Period of Report
2011-07-31

Document Format Files

Seq Description Document Type Size
1 compassbio10qa073111.htm 10-Q/A 730939
2 ex31-1.htm EX-31.1 15082
3 ex32-1.htm EX-32.1 8929
  Complete submission text file 0001185185-11-001665.txt   2174645

Data Files

Seq Description Document Type Size
4 cobi-20110731.xml EX-101.INS 242941
5 cobi-20110731.xsd EX-101.SCH 14681
6 cobi-20110731_cal.xml EX-101.CAL 26394
7 cobi-20110731_def.xml EX-101.DEF 66218
8 cobi-20110731_lab.xml EX-101.LAB 92907
9 cobi-20110731_pre.xml EX-101.PRE 75559
Mailing Address 9650 - 20 AVENUE EDMONTON A0 T6N 1G1
Business Address 9650 - 20 AVENUE EDMONTON A0 T6N 1G1 780-469-2975
COMPASS BIOTECHNOLOGIES INC. (Filer) CIK: 0001327238 (see all company filings)

EIN.: 470930829 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q/A | Act: 34 | File No.: 000-52057 | Film No.: 111115067
SIC: 2834 Pharmaceutical Preparations